{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:23:58Z","timestamp":1791973438981,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00296-021-04998-x","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T08:03:44Z","timestamp":1632297824000},"page":"2031-2039","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Reactive arthritis after COVID-19: a case-based review"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6065-8002","authenticated-orcid":false,"given":"Burhan Fatih","family":"Kocyigit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8953-5196","authenticated-orcid":false,"given":"Ahmet","family":"Akyol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"4998_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00296-021-04792-9","volume":"41","author":"T Velikova","year":"2021","unstructured":"Velikova T, Georgiev T (2021) SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis. Rheumatol Int 41:509\u2013518. https:\/\/doi.org\/10.1007\/s00296-021-04792-9","journal-title":"Rheumatol Int"},{"key":"4998_CR2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.55563\/clinexprheumatol\/xcdary","volume":"38","author":"P Sarzi-Puttini","year":"2020","unstructured":"Sarzi-Puttini P, Giorgi V, Sirotti S, Marotto D, Ardizzone S, Rizzardini G, Antinori S, Galli M (2020) COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheumatol 38:337\u2013342","journal-title":"Clin Exp Rheumatol"},{"key":"4998_CR3","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s10067-020-05073-9","volume":"39","author":"DP Misra","year":"2020","unstructured":"Misra DP, Agarwal V, Gasparyan AY, Zimba O (2020) Rheumatologists\u2019 perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin Rheumatol 39:2055\u20132062. https:\/\/doi.org\/10.1007\/s10067-020-05073-9","journal-title":"Clin Rheumatol"},{"key":"4998_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00296-020-04764-5","volume":"41","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Gasparyan AY, Zimba O (2021) Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic. Rheumatol Int 41:243\u2013256. https:\/\/doi.org\/10.1007\/s00296-020-04764-5","journal-title":"Rheumatol Int"},{"key":"4998_CR5","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1007\/s00296-012-2451-z","volume":"32","author":"AG Sener","year":"2012","unstructured":"Sener AG, Afsar I (2012) Infection and autoimmune disease. Rheumatol Int 32:3331\u20133338. https:\/\/doi.org\/10.1007\/s00296-012-2451-z","journal-title":"Rheumatol Int"},{"key":"4998_CR6","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s10067-020-05190-5","volume":"39","author":"M Soy","year":"2020","unstructured":"Soy M, Keser G, Atag\u00fcnd\u00fcz P, Tabak F, Atag\u00fcnd\u00fcz I, Kayhan S (2020) Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol 39:2085\u20132094. https:\/\/doi.org\/10.1007\/s10067-020-05190-5","journal-title":"Clin Rheumatol"},{"key":"4998_CR7","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, P\u00e9r\u00e9 H, Charbit B, Bondet V, Chenevier-Gobeaux C, Breillat P, Carlier N, Gauzit R, Morbieu C, P\u00e8ne F, Marin N, Roche N, Szwebel TA, Merkling SH, Treluyer JM, Veyer D, Mouthon L, Blanc C, Tharaux PL, Rozenberg F, Fischer A, Duffy D, RieuxLaucat F, Kern\u00e9is Terrier B (2020) Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369:718\u2013724. https:\/\/doi.org\/10.1126\/science.abc6027","journal-title":"Science"},{"key":"4998_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11926-021-01018-6","volume":"23","author":"H Zeidler","year":"2021","unstructured":"Zeidler H, Hudson AP (2021) Reactive arthritis update: spotlight on new and rare infectious agents implicated as pathogens. Curr Rheumatol Rep 23:53. https:\/\/doi.org\/10.1007\/s11926-021-01018-6","journal-title":"Curr Rheumatol Rep"},{"key":"4998_CR9","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1007\/s00296-013-2794-0","volume":"33","author":"A Kuuliala","year":"2013","unstructured":"Kuuliala A, Julkunen H, Paimela L, Peltomaa R, Kautiainen H, Repo H, Leirisalo-Repo M (2013) Double-blind, randomized, placebo-controlled study of three-month treatment with the combination of ofloxacin and roxithromycin in recent-onset reactive arthritis. Rheumatol Int 33:2723\u20132729. https:\/\/doi.org\/10.1007\/s00296-013-2794-0","journal-title":"Rheumatol Int"},{"key":"4998_CR10","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00296-021-04879-3","volume":"41","author":"Y Taniguchi","year":"2021","unstructured":"Taniguchi Y, Nishikawa H, Yoshida T, Terada Y, Tada K, Tamura N, Kobayashi S (2021) Expanding the spectrum of reactive arthritis (ReA): classic ReA and infection-related arthritis including poststreptococcal ReA, Poncet\u2019s disease, and iBCG-induced ReA. Rheumatol Int 41:1387\u20131398. https:\/\/doi.org\/10.1007\/s00296-021-04879-3","journal-title":"Rheumatol Int"},{"key":"4998_CR11","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1007\/s10067-021-05691-x","volume":"40","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Zimba O, Gasparyan AY (2021) COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol 40:2611\u20132619. https:\/\/doi.org\/10.1007\/s10067-021-05691-x","journal-title":"Clin Rheumatol"},{"key":"4998_CR12","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00296-021-04882-8","volume":"41","author":"F Karaarslan","year":"2021","unstructured":"Karaarslan F, Demircio\u011fluG\u00fcneri F, Karde\u015f S (2021) Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews. Rheumatol Int 41:1263\u20131271. https:\/\/doi.org\/10.1007\/s00296-021-04882-8","journal-title":"Rheumatol Int"},{"key":"4998_CR13","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.autrev.2014.01.005","volume":"13","author":"C Selmi","year":"2014","unstructured":"Selmi C, Gershwin ME (2014) Diagnosis and classification of reactive arthritis. Autoimmun Rev 13:546\u2013549. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.005","journal-title":"Autoimmun Rev"},{"key":"4998_CR14","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"4998_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-241375","volume":"14","author":"BL H\u00f8nge","year":"2021","unstructured":"H\u00f8nge BL, Hermansen MF, Storgaard M (2021) Reactive arthritis after COVID-19. BMJ Case Rep 14:e241375. https:\/\/doi.org\/10.1136\/bcr-2020-241375","journal-title":"BMJ Case Rep"},{"key":"4998_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4081\/reumatismo.2021.1374","volume":"73","author":"G El Hasbani","year":"2021","unstructured":"El Hasbani G, Jawad A, Uthman I (2021) Axial and peripheral spondyloarthritis triggered by sars-cov-2 infection: a report of two cases. Reumatismo 73:59\u201363. https:\/\/doi.org\/10.4081\/reumatismo.2021.1374","journal-title":"Reumatismo"},{"key":"4998_CR17","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1093\/rheumatology\/keab009","volume":"60","author":"FL Coath","year":"2021","unstructured":"Coath FL, Mackay J, Gaffney JK (2021) Axial presentation of reactive arthritis secondary to COVID-19 infection. Rheumatology (Oxford) 60:e232\u2013e233. https:\/\/doi.org\/10.1093\/rheumatology\/keab009","journal-title":"Rheumatology (Oxford)"},{"key":"4998_CR18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/rheumatology\/keaa689","volume":"60","author":"HM Schenker","year":"2021","unstructured":"Schenker HM, Hagen M, Simon D, Schett G, Manger B (2021) Reactive arthritis and cutaneous vasculitis after SARS-CoV-2 infection. Rheumatology (Oxford) 60:479\u2013480. https:\/\/doi.org\/10.1093\/rheumatology\/keaa689","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"4998_CR19","first-page":"25","volume":"128","author":"M Di Carlo","year":"2021","unstructured":"Di Carlo M, Tardella M, Salaffi F (2021) Can SARS-CoV-2 induce reactive arthritis? Clin Exp Rheumatol 128(1):25\u201326","journal-title":"Clin Exp Rheumatol"},{"key":"4998_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/jmv.26296","volume":"93","author":"EM Saricaoglu","year":"2021","unstructured":"Saricaoglu EM, Hasanoglu I, Guner R (2021) The first reactive arthritis case associated with COVID-19. J Med Virol 93:192\u2013193. https:\/\/doi.org\/10.1002\/jmv.26296","journal-title":"J Med Virol"},{"key":"4998_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/RHU.0000000000001560","volume":"26","author":"IY Liew","year":"2020","unstructured":"Liew IY, Mak TM, Cui L, Vasoo S, Lim XR (2020) A case of reactive arthritis secondary to coronavirus disease 2019 infection. J Clin Rheumatol 26:233. https:\/\/doi.org\/10.1097\/RHU.0000000000001560","journal-title":"J Clin Rheumatol"},{"key":"4998_CR22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11761","volume":"12","author":"I Jali","year":"2020","unstructured":"Jali I (2020) Reactive arthritis after COVID-19 infection. Cureus 12:e11761. https:\/\/doi.org\/10.7759\/cureus.11761","journal-title":"Cureus"},{"key":"4998_CR23","first-page":"278","volume":"45","author":"I Fragata","year":"2020","unstructured":"Fragata I, Mour\u00e3o AF (2020) Coronavirus disease 19 (COVID-19) complicated with post-viral arthritis. Acta Reumatol Port 45:278\u2013280","journal-title":"Acta Reumatol Port"},{"key":"4998_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001350","volume":"6","author":"K Ono","year":"2020","unstructured":"Ono K, Kishimoto M, Shimasaki T, Uchida H, Kurai D, Deshpande GA, Komagata Y, Kaname S (2020) Reactive arthritis after COVID-19 infection. RMD Open 6:e001350. https:\/\/doi.org\/10.1136\/rmdopen-2020-001350","journal-title":"RMD Open"},{"key":"4998_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218520","author":"L De Stefano","year":"2020","unstructured":"De Stefano L, Rossi S, Montecucco C, Bugatti S (2020) Transient monoarthritis and psoriatic skin lesions following COVID-19. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218520","journal-title":"Ann Rheum Dis"},{"key":"4998_CR26","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1007\/s10067-020-05550-1","volume":"40","author":"M Gasparotto","year":"2021","unstructured":"Gasparotto M, Framba V, Piovella C, Doria A, Iaccarino L (2021) Post-COVID-19 arthritis: a case report and literature review. Clin Rheumatol 40:3357\u20133362. https:\/\/doi.org\/10.1007\/s10067-020-05550-1","journal-title":"Clin Rheumatol"},{"key":"4998_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218281","author":"N Yokogawa","year":"2020","unstructured":"Yokogawa N, Minematsu N, Katano H, Suzuki T (2020) Case of acute arthritis following SARS-CoV-2 infection. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218281","journal-title":"Ann Rheum Dis"},{"key":"4998_CR28","doi-asserted-by":"publisher","first-page":"rkab001","DOI":"10.1093\/rap\/rkab001","volume":"5","author":"NP Sureja","year":"2021","unstructured":"Sureja NP, Nandamuri D (2021) Reactive arthritis after SARS-CoV-2 infection. Rheumatol Adv Pract 5:rkab001. https:\/\/doi.org\/10.1093\/rap\/rkab001","journal-title":"Rheumatol Adv Pract"},{"key":"4998_CR29","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9698","volume":"12","author":"Z Danssaert","year":"2020","unstructured":"Danssaert Z, Raum G, Hemtasilpa S (2020) Reactive arthritis in a 37-year-old female with SARS-CoV2 infection. Cureus 12:e9698. https:\/\/doi.org\/10.7759\/cureus.9698","journal-title":"Cureus"},{"key":"4998_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.448","author":"W Saikali","year":"2021","unstructured":"Saikali W, Gharib S (2021) The first non-radiographic axial spondyloarthrits with COVID-19. Immun Inflamm Dis. https:\/\/doi.org\/10.1002\/iid3.448","journal-title":"Immun Inflamm Dis"},{"key":"4998_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40794-021-00142-6","volume":"7","author":"K Shokraee","year":"2021","unstructured":"Shokraee K, Moradi S, Eftekhari T, Shajari R, Masoumi M (2021) Reactive arthritis in the right hip following COVID-19 infection: a case report. Trop Dis Travel Med Vaccines 7:18. https:\/\/doi.org\/10.1186\/s40794-021-00142-6","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"4998_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkaa052.014","author":"M Gibson","year":"2020","unstructured":"Gibson M, Sampat K, Coakley G (2020) A self-limiting symmetrical polyarthritis following COVID-19 infection. Rheumatol Adv Pract. https:\/\/doi.org\/10.1093\/rap\/rkaa052.014","journal-title":"Rheumatol Adv Pract"},{"key":"4998_CR33","doi-asserted-by":"publisher","unstructured":"Ghauri IG, Mukarram MS, Ishaq K, Riaz SU (2020) Post COVID-19 reactive arthritis: an emerging existence in the spectrum of musculoskeletal complications of SARS-CoV-2 \u0131nfection. J Clin Stud Med Case Rep 7:101. https:\/\/doi.org\/10.24966\/CSMC-8801\/100101","DOI":"10.24966\/CSMC-8801\/100101"},{"key":"4998_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026089","volume":"100","author":"G Cincinelli","year":"2021","unstructured":"Cincinelli G, Di Taranto R, Orsini F, Rindone A, Murgo A, Caporali R (2021) A case report of monoarthritis in a COVID-19 patient and literature review: Simple actions for complex times. Medicine (Baltimore) 100:e26089. https:\/\/doi.org\/10.1097\/MD.0000000000026089","journal-title":"Medicine (Baltimore)"},{"key":"4998_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fimmu.2017.00243","volume":"8","author":"MI Arleevskaya","year":"2017","unstructured":"Arleevskaya MI, Manukyan G, Inoue R, Aminov R (2017) Editorial: microbial and environmental factors in autoimmune and inflammatory diseases. Front Immunol 8:243. https:\/\/doi.org\/10.3389\/fimmu.2017.00243","journal-title":"Front Immunol"},{"key":"4998_CR36","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00296-020-04639-9","volume":"40","author":"S Shah","year":"2020","unstructured":"Shah S, Danda D, Kavadichanda C, Das S, Adarsh MB, Negi VS (2020) Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment. Rheumatol Int 40:1539\u20131554. https:\/\/doi.org\/10.1007\/s00296-020-04639-9","journal-title":"Rheumatol Int"},{"key":"4998_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/08916930500484708","volume":"39","author":"B Kim","year":"2006","unstructured":"Kim B, Kaistha SD, Rouse BT (2006) Viruses and autoimmunity. Autoimmunity 39:71\u201377. https:\/\/doi.org\/10.1080\/08916930500484708","journal-title":"Autoimmunity"},{"key":"4998_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2020.100051","volume":"3","author":"J Lyons-Weiler","year":"2020","unstructured":"Lyons-Weiler J (2020) Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity. J Transl Autoimmun 3:100051. https:\/\/doi.org\/10.1016\/j.jtauto.2020.100051","journal-title":"J Transl Autoimmun"},{"key":"4998_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s40588-020-00152-6","author":"I Bentaleb","year":"2020","unstructured":"Bentaleb I, Abdelghani KB, Rostom S, Amine B, Laatar A, Bahiri R (2020) Reactive arthritis: update. Curr Clin Microbiol Rep. https:\/\/doi.org\/10.1007\/s40588-020-00152-6","journal-title":"Curr Clin Microbiol Rep"},{"key":"4998_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5455\/medarh.2015.69.42-45","volume":"69","author":"A Lahu","year":"2015","unstructured":"Lahu A, Backa T, Ismaili J, Lahu V, Saiti V (2015) Modes of presentation of reactive arthritis based on the affected joints. Med Arch 69:42\u201345. https:\/\/doi.org\/10.5455\/medarh.2015.69.42-45","journal-title":"Med Arch"},{"key":"4998_CR41","doi-asserted-by":"publisher","unstructured":"Kim PS, Klausmeier TL, Orr DP. Reactive arthritis: a review. J Adolesc Health 44:309\u2013315. https:\/\/doi.org\/10.1016\/j.jadohealth.2008.12.007","DOI":"10.1016\/j.jadohealth.2008.12.007"},{"key":"4998_CR42","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/jdv.12741","volume":"29","author":"PG Stavropoulos","year":"2015","unstructured":"Stavropoulos PG, Soura E, Kanelleas A, Katsambas A, Antoniou C (2015) Reactive arthritis. J Eur Acad Dermatol Venereol 29:415\u2013424. https:\/\/doi.org\/10.1111\/jdv.12741","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4998_CR43","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s10067-020-05202-4","volume":"39","author":"S Ib\u00e1\u00f1ez","year":"2020","unstructured":"Ib\u00e1\u00f1ez S, Mart\u00ednez O, Valenzuela F, Silva F, Valenzuela O (2020) Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy? Clin Rheumatol 39:2461\u20132465. https:\/\/doi.org\/10.1007\/s10067-020-05202-4","journal-title":"Clin Rheumatol"},{"key":"4998_CR44","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00296-005-0094-z","volume":"26","author":"A Ozg\u00fcl","year":"2006","unstructured":"Ozg\u00fcl A, Dede I, Taskaynatan MA, Aydogan H, Kalyon TA (2006) Clinical presentations of chlamydial and non-chlamydial reactive arthritis. Rheumatol Int 26:879\u2013885. https:\/\/doi.org\/10.1007\/s00296-005-0094-z","journal-title":"Rheumatol Int"},{"key":"4998_CR45","doi-asserted-by":"publisher","first-page":"129","DOI":"10.7861\/clinmedicine.16-2-129","volume":"16","author":"M Marks","year":"2016","unstructured":"Marks M, Marks JL (2016) Viral arthritis. Clin Med (Lond) 16:129\u2013134. https:\/\/doi.org\/10.7861\/clinmedicine.16-2-129","journal-title":"Clin Med (Lond)"},{"key":"4998_CR46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10067-017-3911-3","volume":"37","author":"HR Garcia Ferrer","year":"2018","unstructured":"Garcia Ferrer HR, Azan A, Iraheta I, Von Feldt J, Espinoza LR, Manasson J, Scher JU, Garcia Kutzbach A, Ogdie A (2018) Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up. Clin Rheumatol 37:415\u2013422. https:\/\/doi.org\/10.1007\/s10067-017-3911-3","journal-title":"Clin Rheumatol"},{"key":"4998_CR47","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1136\/ard.2004.027524","volume":"64","author":"T Hannu","year":"2005","unstructured":"Hannu T, Mattila L, Siitonen A, Leirisalo-Repo M (2005) Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study. Ann Rheum Dis 64:594\u2013598. https:\/\/doi.org\/10.1136\/ard.2004.027524","journal-title":"Ann Rheum Dis"},{"key":"4998_CR48","doi-asserted-by":"publisher","unstructured":"Sieper J. Pathogenesis of reactive arthritis. Curr Rheumatol Rep 3:412\u2013418. https:\/\/doi.org\/10.1007\/s11926-996-0012-8","DOI":"10.1007\/s11926-996-0012-8"},{"key":"4998_CR49","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13075-017-1453-3","volume":"19","author":"M Protopopov","year":"2017","unstructured":"Protopopov M, Sieper J, Haibel H, Listing J, Rudwaleit M, Poddubnyy D (2017) Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Res Ther 19:240. https:\/\/doi.org\/10.1186\/s13075-017-1453-3","journal-title":"Arthritis Res Ther"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04998-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-04998-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04998-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T22:33:21Z","timestamp":1673303601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-04998-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["4998"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-04998-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,22]]},"assertion":[{"value":"23 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The presented patient provided signed consent for the publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}